Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06146166 · ClinicalTrials.gov registry record · NA

The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome

A NA study of Hair Thinning, sponsored by Integrative Skin Science and Research.

Active
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06146166: Active NA study of Hair Thinning, sponsored by Integrative Skin Science and Research.

NCT06146166 is a NA study of Hair Thinning that is active but no longer recruiting, run by Integrative Skin Science and Research. The registered enrollment target is 60 participants, roughly in line with the 60-participant average among 10 other Hair Thinning trials with a reported enrollment target. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06146166, a NA study of Hair Thinning, is active but no longer recruiting, sponsored by Integrative Skin Science and Research.

ACTIVE NOT RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to assess how an oral herbal supplement influences hair density, shine, growth, and microbiome.

Conditions Studied

Interventions

  • DIETARY_SUPPLEMENT Oral herbal supplement
  • DIETARY_SUPPLEMENT Oral placebo supplement

Study Locations (1)

California

  • Integrative Skin and Research - Sacramento

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-02-22
Est. Completion 2025-01-10
Phase NA

What the registry record for NCT06146166 still lists

NCT06146166 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 60 participants, a relatively small participant target, roughly in line with the 60-participant average among 10 other Hair Thinning trials with a reported enrollment target.

The record links to 1 condition, with Hair Thinning appearing as the primary indexed condition, and to 2 interventions - of which Oral herbal supplement is the first listed.

NCT06146166 reports a single indexed study location in California.

Frequently Asked Questions

What is clinical trial NCT06146166 about?

NCT06146166 is a clinical study titled "The Effects of an Oral Hair Supplement on Hair Density, Growth, and Microbiome". The purpose of this study is to assess how an oral herbal supplement influences hair density, shine, growth, and microbiome.

What is the current status of trial NCT06146166?

This trial is currently active not recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-02-22. Estimated completion is 2025-01-10.

What conditions does trial NCT06146166 study?

This clinical trial studies the following conditions: Hair Thinning.

What interventions are being tested in trial NCT06146166?

The interventions under investigation include: Oral herbal supplement (DIETARY_SUPPLEMENT), Oral placebo supplement (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06146166?

This trial is sponsored by Integrative Skin Science and Research, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06146166 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Hair Thinning

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT06146166's enrollment target sits among peer trials

60 5th of 10 higher than 6 of 10 other Hair Thinning trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Hair Thinning trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00576069 · 60 participants

    Mechanism(s)of Airflow Limitation in Moderate-severe Persistent Asthma

  • NCT01297400 · 60 participants · Phase 2

    Phase 2 Pilot Study of the Safety and Efficacy of Topical MW-III in Thermal Burns

  • NCT01734122 · 60 participants

    Stereotactic Radiosurgery for Essential Tremor and Parkinsonian Tremor

  • NCT01804634 · 60 participants · Phase 2

    Reduced Intensity Haploidentical BMT for High Risk Solid Tumors

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT06146166, the US trial registry maintained by the National Library of Medicine. NCT06146166 (small enrollment · single site footprint · active not recruiting) retrieved and formatted by PlainTrial, see methodology.